About
Jake Taylor-King is co-founder and Chief Innovation Officer of Relation Therapeutics, a London-based techbio company using computational and experimental approaches for drug discovery. Before Relation, he completed postdoctoral work at ETH Zurich in single-cell bioinformatics and served as Head of Bioinformatics at Empyrean Therapeutics. His academic training spans the University of Bristol, the University of Oxford, and the University of Cambridge, and his public commentary centers on AI, genomics, precision medicine, and translational biotech.
Areas of interest
biotechtechbioAImachine learninggenomicssingle-cell biologybioinformaticsprecision medicinedrug discoveryosteoporosisosteomicscomputational biology